Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Orthofix Intl NV (OFIX)

Orthofix Intl NV (OFIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 556,380
  • Shares Outstanding, K 39,600
  • Annual Sales, $ 799,490 K
  • Annual Income, $ -126,000 K
  • EBIT $ -93 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.79
  • Price/Sales 0.67
  • Price/Cash Flow N/A
  • Price/Book 1.29

Options Overview Details

View History
  • Implied Volatility 91.42% (+12.39%)
  • Historical Volatility 28.16%
  • IV Percentile 26%
  • IV Rank 32.30%
  • IV High 180.57% on 10/17/25
  • IV Low 48.88% on 08/18/25
  • Expected Move (DTE 34) 1.70 (12.10%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 5
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 221
  • Open Int (30-Day) 207
  • Expected Range 12.35 to 15.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.31
  • Number of Estimates 1
  • High Estimate -0.31
  • Low Estimate -0.31
  • Prior Year -0.75
  • Growth Rate Est. (year over year) +58.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.03 +0.14%
on 01/16/26
16.42 -14.43%
on 01/08/26
-1.50 (-9.65%)
since 12/16/25
3-Month
14.03 +0.14%
on 01/16/26
16.99 -17.30%
on 11/04/25
-1.20 (-7.87%)
since 10/16/25
52-Week
10.24 +37.21%
on 06/23/25
20.48 -31.40%
on 02/25/25
-3.88 (-21.64%)
since 01/16/25

Most Recent Stories

More News
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulseâ„¢ technology using its proprietary Nanosecond Pulsed Field Ablationâ„¢ (nanosecond PFA or nsPFAâ„¢) energy, today announced...

HYPR : 1.2000 (-1.64%)
OFIX : 14.05 (-2.43%)
SPNC : 38.45 (unch)
AVNS : 12.34 (unch)
PLSE : 14.25 (+1.06%)
SWAV : 334.75 (-0.02%)
Orthofix: Q3 Earnings Snapshot

Orthofix: Q3 Earnings Snapshot

OFIX : 14.05 (-2.43%)
Orthofix Reports Third Quarter 2025 Financial Results

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2025, narrowed its full-year 2025 net sales...

OFIX : 14.05 (-2.43%)
Orthofix to Participate in Upcoming Investor Conferences

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial...

OFIX : 14.05 (-2.43%)
Orthofix to Report Third Quarter 2025 Financial Results

Company to Host Conference Call on Tuesday, November 4, 2025, at 8:30 am Eastern Time

OFIX : 14.05 (-2.43%)
Orthofix: Q2 Earnings Snapshot

Orthofix: Q2 Earnings Snapshot

OFIX : 14.05 (-2.43%)
Orthofix Reports Second Quarter 2025 Financial Results

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2025, and reaffirmed its full-year 2025 financial...

OFIX : 14.05 (-2.43%)
Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference

Wednesday, August 13, 2025 at 9:00 am Eastern Time

OFIX : 14.05 (-2.43%)
Orthofix: Q1 Earnings Snapshot

Orthofix: Q1 Earnings Snapshot

OFIX : 14.05 (-2.43%)
Orthofix: Q4 Earnings Snapshot

Orthofix: Q4 Earnings Snapshot

OFIX : 14.05 (-2.43%)

Business Summary

Orthofix Medical Inc. develops, produces and markets medical devices. The Company offers spine fixation, biological and other orthopedic and spine solutions. Orthofix Medical Inc., formerly known as Orthofix International N.V., is headquartered in Lewisville, Texas.

See More

Key Turning Points

3rd Resistance Point 14.73
2nd Resistance Point 14.58
1st Resistance Point 14.32
Last Price 14.05
1st Support Level 13.91
2nd Support Level 13.76
3rd Support Level 13.50

See More

52-Week High 20.48
Fibonacci 61.8% 16.57
Fibonacci 50% 15.36
Fibonacci 38.2% 14.15
Last Price 14.05
52-Week Low 10.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar